iSERA Lifesciences — 360° view

iSERA Lifesciences, a company in the Computers - Software & Consulting industry, reported revenue of ₹1.16 crore and net profit of ₹0.55 crore for the March 2026 quarter.

iSERA Lifesciences (BSE: ISERA) closed at ₹143.90 on 20 Nov 2026, up 1359.4% over the past year. Its market capitalisation is ₹354 crore.

Share price
₹143.90 (20 Nov 2026)
Market cap
₹354 Cr (20 Nov 2026)
Revenue
₹1 Cr (March 2026 quarter)
Net profit
₹1 Cr (March 2026 quarter)
ROCE
5.95% (FY26)
ROE
6.38% (FY26)
Book value
₹9.25 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹151.05 / ₹10.05 (20 Nov 2026)
1-year return
1359.4% (to 20 Nov 2026)
Sector
Information Technology
Industry
Computers - Software & Consulting
Symbol
BSE: ISERA

Incorporated in 1993, Covidh Technologies Ltd is engaged in IT/ITES business.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.